Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +40.66% | +21.75% | +62.76% | +63.14% | +115.02% |
| Weighted Average Shares Diluted Growth | +40.66% | +21.75% | +62.76% | +63.14% | +115.02% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +41.63% | -34.59% | -47.56% | +44.48% | +87.85% |
| Book Value per Share Growth | +0.00% | -88.33% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -62.70% | +0.00% | -32.44% | -45.42% | -100.00% |
| R&D Expense Growth | -21.33% | -44.78% | -28.88% | -33.30% | -68.92% |
| SG&A Expenses Growth | -19.46% | +6.05% | +13.39% | -7.74% | +18.34% |